
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration has granted expanded approval to protease inhibitor Prezista for use in first-line therapy among treatment-naive HIVers as well as full approval for its use among treatment-experienced adults. Prezista previously was approved under an accelerated review program only for HIVers with drug resistance. --------------------- A study in the journal AIDS recommends several guidelines to monitor HIVers for emerging resistance to Prezista, including the development of two viral mutations conveying drug resistance and high viral loads after 24 weeks of treatment. Patients who've developed resistance to Prezista also should be monitored for possible cross-resistance to Aptivus, according to the study. --------------------- An analysis in the journal AIDS has shown that newer once-daily, fixed-dose antiretroviral regimens like Epzicom, Atripla, and Truvada are more durable than earlier antiretroviral drugs. Durability is vital to long-term treatment success since anti-HIV medications must be taken indefinitely. --------------------- Data from two long-term studies reported in the journal AIDS confirm the results of previous research that has shown that Viread can negatively affect kidney function, but they also show that kidney toxicity is generally mild and is not linked with the development of more serious renal disease. --------------------- The FDA has announced that it is investigating possible hemarthrosis, a side effect marked by bleeding into the body's joints, with the nonnuke Intelence. The agency also is investigating the hepatitis B treatment Tyzeka for possible peripheral neuropathy. --------------------- Myriad Genetics is launching Phase II human trials of experimental maturation inhibitor vivecon (MPC-9055). The drug, part of an entirely new class of antiretrovirals, targets one of the final stages of viral replication by interfering with the assembly of newly created HIV particles. --------------------- The FDA has made changes to the label of protease inhibitor Norvir to indicate that the drug might cause heart rhythm abnormalities. The label now says Norvir should be used with caution in patients with heart disease or preexisting cardiac abnormalities. --------------------- Merck has launched a study of integrase inhibitor Isentress for use in first-line therapy among treatment-naive HIVers. Isentress is currently approved only for patients with drug-resistant infections. --------------------- Studies of Tibotec experimental nonnuke rilpivirine (TMC278) have shown that the drug might offer months of sustained anti-HIV activity after a single injection of a 'depot formulation' that releases medication in the body slowly over time. Additional studies have been planned. --------------------- A study of the antiepileptic drug Lyrica (pregabalin) for the treatment of HIV-associated peripheral neuropathy has shown that the medication was only slightly more effective in reducing pain scores than a placebo. The medication has been shown to help with other neuropathic pain syndromes. --------------------- HIVers treated with interferon for hepatitis C coinfection could face higher risks for neuropsychiatric side effects if also taking Sustiva, researchers report in the Journal of Acquired Immune Deficiency Syndromes. Combining the two medications boosted reported mood disorders by 50%. --------------------- An analysis of Spanish HIVers has shown that risks for progressive multifocal leukoencephalopathy, a potentially severe brain infection, remain high even in the presence of successful antiretroviral treatment. Many of the 61 PML cases diagnosed occurred among HIVers with undetectable viral loads and CD4-cell counts above 200.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM